Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2017.12.21, EP 17382884
A. MUKHOPADHYAY ET AL: "Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors", CLINICAL CANCER RESEARCH, vol. 16, no. 8, 6 April 2010 (2010-04-06), pages 2344-2351, XP055496291, US ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-09-2758 (B1)
ALHILLI MARIAM M ET AL: "In vivoanti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma", GYNECOLOGIC ONCOLOGY, ACADEMIC PRESS, LONDON, GB, vol. 143, no. 2, 8 September 2016 (2016-09-08), pages 379-388, XP029775452, ISSN: 0090-8258, DOI: 10.1016/J.YGYNO.2016.08.328 (B1)
C CRUZ ET AL: "RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer", ANNALS OF ONCOLOGY., vol. 29, no. 5, 4 April 2018 (2018-04-04), pages 1203-1210, XP055496237, NL ISSN: 0923-7534, DOI: 10.1093/annonc/mdy099 (B1)
DATABASE EMBASE [Online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 1 July 2017 (2017-07-01), KOCHUPURAKKAL B S ET AL: "Development of a RAD51-based assay for determining homologous recombination proficiency and PARP inhibitor sensitivity", Database accession no. EMB-618663886 & KOCHUPURAKKAL B S ET AL: "Development of a RAD51-based assay for determining homologous recombination proficiency and PARP inhibitor sensitivity", CANCER RESEARCH 20170701 AMERICAN ASSOCIATION FOR CANCER RESEARCH INC. NLD, vol. 77, no. 13, Supplement 1, 1 July 2017 (2017-07-01), ISSN: 1538-7445 (B1)
DATABASE EMBASE [Online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 1 July 2017 (2017-07-01), KOCHUPURAKKAL B S ET AL: "Development of a RAD51-based assay for determining homologous recombination proficiency and PARP inhibitor sensitivity", XP002783505, Database accession no. EMB-618663886 & CANCER RESEARCH 20170701 AMERICAN ASSOCIATION FOR CANCER RESEARCH INC. NLD, vol. 77, no. 13, Supplement 1, 1 July 2017 (2017-07-01), ISSN: 1538-7445 (B1)
HENNING WILLERS ET AL: "DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity", SEMINARS IN RADIATION ONCOLOGY, vol. 25, no. 4, 1 October 2015 (2015-10-01), pages 237-250, XP055545282, US ISSN: 1053-4296, DOI: 10.1016/j.semradonc.2015.05.007 (B1)
WO-A2-2008/066624 (B1)
US-A1- 2013 210 779 (B1)
US-A1- 2014 357 659 (B1)
US-A1- 2016 296 633 (B1)
US-A1- 2017 209 594 (B1)
WO-A1-2010/082821 (B1)
US-A1- 2011 288 080 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3729097)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP3729097)
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Neste fornyelse/årsavgift:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 7. avg. år (EP) | 2024.12.30 | 2860 | COMPUTER PACKAGES INC. | Betalt og godkjent |
32405437 expand_more expand_less | 2024.04.25 | 7150 | ZACCO NORWAY AS | Betalt |
Valideringsgebyr EP-patent
7150 = 1 X 7150
|